|
|
|
|
Quality of life correlated with vitality,general health,and mental health in the SF-36,each of which patients rated as more important than clinicians and for each of which patients scored lower than the controls. Patients with multiple sclerosis,and possibly those with other chronic disease,are less concerned than their clinicians about physical disability in their illness.clinical trials in multiple sclerosis should assess the effect of treatment on the other elements of health status that patients consider important which are also affected by the disease process,are more closely related to overall health related to quality of life,and may well be adversely affected by side effects of treatment. |
|